Global Director – Icon Cancer Centre – Ross Koscharsky
Ross Koscharsky has been Chief Financial Officer (CFO) since the formation of Icon Group, playing a key role in Icon’s growth. Having led each of our acquisitions, Ross is adept at leading change and successfully driving significant growth and integration. His unparalleled knowledge of Icon Group’s global operations, deep executive and doctor relationships, and proven leadership skills mean Ross is perfectly placed to lead the next stage of Icon’s cancer care and research portfolio across Australia, New Zealand, Singapore, Hong Kong, and Mainland China.
Current cancer division leaders – Paul Fenton (CEO Icon Cancer Centre AU/NZ), Sophie Mepham (Group Executive Research Global), Chelsea Ren (CEO Icon Cancer Centre China) and Serena Wee (CEO Icon Cancer Centre ASEAN and Hong Kong) will report to Ross.
Ross officially steps into this role following the appointment of the Group’s new Chief Financial Officer.
“Ross’ strategic and operational knowledge of Icon Group is immense and there’s no doubt he has the credentials to direct our cancer care services on a global scale while upholding our commitment to clinical excellence and patient care.” said Icon Group Chief Executive Officer (CEO) Mark Middleton.